#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Meningitis meningococcal Neoplasm malignant Cardiomyopathy Piriformis syndrome Mitochondrial DNA depletion Antisynthetase syndrome Pleural mesothelioma malignant Hypochromic anaemia Thromboangiitis obliterans Glioma Anaplastic large cell lymphoma T- and null-cell types Arrhythmia Richter's syndrome Fibrosarcoma Chronic graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Life with Disease Testicular leiomyosarcoma Myxofibrosarcoma – Life with Disease Progressive supranuclear palsy – Diagnostics Myelodysplastic syndrome with excess blasts – Diagnostics Alveolar rhabdomyosarcoma – Diagnostics Angiosarcoma metastatic – Treatment Hereditary ataxia – Diagnostics Primary mediastinal large B-cell lymphoma – Life with Disease Leiomyosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Arachis Hypogaea (762) Vancomycin 6QC-ICG Dordaviprone Golimumab Gsk4532990A Tazobactam Levobupivacaine Hydrochloride Atomoxetine Iodine (123I) Iobenguane A/H1N1 INFLUENZA VACCINE Nizatidine PARECOXIB CARBOMER 980 Bi 1839100 Fitusiran Doxazosin Mk-1084 HUMAN PLASMA Mifepristone More therapies…

    Learn about Your Condition

    Glucose tolerance impaired Hyperkalaemia Infertility Medication overuse headache Kidney transplant rejection Cognitive disorder Spinal pain Lipid metabolism disorder Mantle cell lymphoma stage IV Subdural haematoma Sexual dysfunction Vaginal haemorrhage Ocular melanoma Poor quality sleep Vascular calcification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej…

Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej

Ul. Terebelska 57/65, Biala Podlaska, 21-500, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Azacitidine
    • Cytarabine
    Belgium Czechia France Germany Greece Hungary +4

  • Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Gemcitabine
    Austria France Germany Greece Italy Poland +4

  • Study on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Czechia Germany The Netherlands Poland Spain

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Amivantamab
    • Bevacizumab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +4

  • Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amivantamab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Saruparib
    • Camizestrant
    • Exemestane
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Eribulin Mesylate
    • Vinorelbine
    • Trastuzumab
    Austria Belgium France Germany Greece Italy +2

  • Study Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pirtobrutinib
    • Ibrutinib
    Austria Belgium Czechia France Germany Hungary +3

  • Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Disodium Folinate
    • Trametinib
    • Rucaparib
    Austria Belgium Czechia France Germany Greece +4
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!